These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 889682)

  • 1. Intravascular coagulation resulting from intravenous injection of C. parvum in mice.
    Lampert IA; Jones PD; Sadler TE; Castro JE
    Br J Cancer; 1977 Jul; 36(1):15-22. PubMed ID: 889682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological changes of intravascular coagulation in mice resulting from intravenous injection of C. parvum.
    Sadler TE; Lampert IA; Jones PD; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():421-6. PubMed ID: 608532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of C. Parvum-induced coagulopathy in mice.
    Mitcheson HD; Hilgard P; McCraw A; Castro JE
    Br J Cancer; 1980 Jan; 41(1):117-22. PubMed ID: 7362773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular coagulation in the development of massive hepatic necrosis induced by Corynebacterium parvum and endotoxin in rats.
    Yamada S; Ogata I; Hirata K; Mochida S; Tomiya T; Fujiwara K
    Scand J Gastroenterol; 1989 Apr; 24(3):293-8. PubMed ID: 2660248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT; Milas L
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabelling of Corynebacterium parvum and its distribution in mice.
    Sadler TE; Cramp WA; Castro JE
    Br J Cancer; 1977 Mar; 35(3):357-68. PubMed ID: 851511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Corynebacterium parvum on murine myeloid leukaemia.
    Bjornsson S; Preisler H; Pavelic Z
    Br J Cancer; 1978 Dec; 38(6):703-8. PubMed ID: 217398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice.
    McIntosh LC; Pugh-Humphreys RG; Thomson AW
    Br J Cancer; 1981 Apr; 43(4):496-504. PubMed ID: 7236491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of intravenous injection of two different strains of Corynebacterium parvum in the mouse.
    Sadler TE; Jones PD; Castro JE; Lampert IA
    Br J Exp Pathol; 1979 Dec; 60(6):627-31. PubMed ID: 540104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
    O'Neill GJ; Stebbing N
    Br J Cancer; 1980 Feb; 41(2):243-9. PubMed ID: 7370164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
    Castro JE; Sadler TE; Jones PD
    Dev Biol Stand; 1977 Apr 13-15; 38():277-81. PubMed ID: 608510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of 3H-thymidine-labelled C. parvum in mice.
    Sadler TE; Cramp WA; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():137-43. PubMed ID: 608501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by the Landschütz ascites carcinoma of the granulomatous inflammatory response to C. parvum.
    McIntosh LC; Pugh-Humphreys RG; Fraser RA; Thomson AW
    Br J Cancer; 1982 Apr; 45(4):598-612. PubMed ID: 7073950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
    Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
    Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies using labelled C. parvum preparations in mice.
    Scott MT
    Dev Biol Stand; 1977 Apr 13-15; 38():123-7. PubMed ID: 608498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect.
    Mitcheson HD; Sadler TE; Castro JE
    Br J Cancer; 1980 Mar; 41(3):407-14. PubMed ID: 7387830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Corynebacterium parvum on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice.
    Ruittenberg EJ; van Noorle Jansen LM
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):197-205. PubMed ID: 808049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by Corynebacterium parvum. 1. Variable effects on anti-sheep erythrocyte antibody responses.
    Ghaffar A; Sigel MM
    Immunology; 1978 Nov; 35(5):685-93. PubMed ID: 363603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.